A258540 Stock Overview
SL Therapeutics Inc. engages in cell therapy and medical device businesses.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
SL Therapeutics, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₩600.00 |
52 Week High | ₩2,300.00 |
52 Week Low | ₩376.00 |
Beta | 0 |
1 Month Change | -31.51% |
3 Month Change | 2.04% |
1 Year Change | -69.99% |
3 Year Change | -90.32% |
5 Year Change | -91.00% |
Change since IPO | -86.96% |
Recent News & Updates
Recent updates
Shareholder Returns
A258540 | KR Life Sciences | KR Market | |
---|---|---|---|
7D | -21.8% | 2.5% | 0.02% |
1Y | -70.0% | 6.5% | 11.3% |
Return vs Industry: A258540 underperformed the KR Life Sciences industry which returned 6.5% over the past year.
Return vs Market: A258540 underperformed the KR Market which returned 11.3% over the past year.
Price Volatility
A258540 volatility | |
---|---|
A258540 Average Weekly Movement | 15.2% |
Life Sciences Industry Average Movement | 6.6% |
Market Average Movement | 5.2% |
10% most volatile stocks in KR Market | 12.0% |
10% least volatile stocks in KR Market | 2.4% |
Stable Share Price: A258540's share price has been volatile over the past 3 months.
Volatility Over Time: A258540's weekly volatility (15%) has been stable over the past year, but is still higher than 75% of KR stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2011 | n/a | Jong Sung Choi | https://www.stemlab.co.kr |
SL Therapeutics Inc. engages in cell therapy and medical device businesses. The company develops cell therapeutic solutions based on its cell reprogramming technology to treat various diseases with a focus on spinal cord injury, and age and genetically related diseases; and hair follicle cells, skin cells, and cells of the central nervous system. It also manufactures automated magnetic resonance imaging systems; and Supra Elite and Dexino bone mineral density measurement devices.
SL Therapeutics, Inc. Fundamentals Summary
A258540 fundamental statistics | |
---|---|
Market cap | ₩3.28b |
Earnings (TTM) | ₩0 |
Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs A258540 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
A258540 income statement (TTM) | |
---|---|
Revenue | ₩0 |
Cost of Revenue | ₩0 |
Gross Profit | ₩0 |
Other Expenses | ₩0 |
Earnings | ₩0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did A258540 perform over the long term?
See historical performance and comparison